Dr. Jeffrey R. Jay, M.D

Dr. Jeffrey R. Jay, M.D. as of June 30, 2012

Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.

Dr. Jeffrey R. Jay, M.D. holds 31 positions in its portfolio as reported in the June 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
OncoGenex Pharmaceuticals 10.1 $9.9M 734k 13.44
Oncothyreon 9.3 $9.1M 2.0M 4.68
Santarus 8.0 $7.9M 1.1M 7.09
Insulet Corporation (PODD) 7.6 $7.5M 350k 21.37
Rigel Pharmaceuticals (RIGL) 6.8 $6.7M 720k 9.30
China Kanghui Holdings 6.5 $6.4M 325k 19.70
Abiomed 6.4 $6.3M 275k 22.82
Vanda Pharmaceuticals (VNDA) 5.5 $5.4M 1.2M 4.40
Osiris Therapeutics 4.0 $3.9M 358k 11.00
Biodel 3.6 $3.5M 1.4M 2.58
Pain Therapeutics 3.1 $3.1M 651k 4.69
Targacept 3.0 $3.0M 688k 4.30
Amarin Corporation (AMRN) 3.0 $2.9M 204k 14.46
Aastrom Biosciences 2.4 $2.4M 1.1M 2.15
INC Ventrus Biosciences 2.4 $2.3M 539k 4.27
RTI Biologics 1.9 $1.9M 500k 3.76
ACADIA Pharmaceuticals (ACAD) 1.8 $1.8M 1.0M 1.76
Palatin Technologies 1.7 $1.6M 3.3M 0.50
NPS Pharmaceuticals 1.6 $1.6M 180k 8.61
Dex (DXCM) 1.5 $1.5M 115k 12.96
Spectranetics Corporation 1.4 $1.4M 120k 11.42
Synergetics USA 1.3 $1.3M 294k 4.46
Cardica 1.3 $1.3M 695k 1.88
Columbia Laboratories 1.3 $1.3M 1.9M 0.68
Trius Therapeutics 1.2 $1.2M 200k 5.76
Merit Medical Systems (MMSI) 1.0 $967k 70k 13.81
Alphatec Holdings 0.9 $925k 503k 1.84
Discovery Laboratories 0.8 $823k 355k 2.32
Tengion 0.3 $266k 90k 2.95
Repligen Corporation (RGEN) 0.1 $68k 16k 4.33
AMAG Pharmaceuticals 0.0 $2.0k 150.00 13.33